Global Markets
Home›Global Markets›North America›Medicaid seeks tighter oversight of autism therapy spe…
Medicaid seeks tighter oversight of autism therapy spending
The program’s spending on therapy has risen fivefold since 2021, outpacing diagnosis growth and prompting concerns about overprescribing and fraud.
The New York Times Business reports that Medicaid is urging states to increase oversight of autism therapy services.
According to the outlet, Medicaid spending on the therapy has quintupled since 2021, a pace that significantly exceeds growth in diagnoses.
The paper says the acceleration has raised concerns about potential overprescribing and fraud, which have become central to the push for tighter controls.
← Newer storyOil slides toward three-week lows on hopes Strait of Hormuz reopensOlder story →Pentagon cancels $300 million lithium carbonate tender for strategic…
More like this
Global MarketsU.S. trade deficit narrows in June as imports fall